EIPG Newsletter

EIPG: Consultation calls and Coming into effect documents

Several consultation calls relevant for industrial pharmacists are closing by the end of September 2018. A dedicated page on the EIPG's website also summarises guidelines coming into effect on 1st September 2018

The Membership of EIPG

EIPG represents at the European level the national, professional organisations of pharmacists employed in the pharmaceutical or allied industries. Its 16 Members Associations are involved in the education and promotion of the figure of industrial pharmacists and in dealing with technical issues typical of their role within the pharmaceutical industry

3D printing, a disruptive technology still lacking regulatory guidance in the EU

Additive manufacturing offers a great potential for the manufacturing of pharmaceutical products, but it is a very complex process and still lacking regulatory guidance in the EU. In the US, the FDA published in 2017 a guideline for the additive manufacturing of medical devices

The new Horizon Europe is coming

Horizon Europe, the new FP9 European framework programme for research and innovation, is due to start in 2021 and shall focus on Open Science and sharing of excellence. A mission-oriented approach based on real needs coming from EU's citizens is at the centre of the proposal of the European Commission

Italy: The main themes discussed at the annual AFI Symposium

All main themes in the field of pharmaceuticals have been addressed during the 58°AFI Symposium, the annual meeting of the Italian pharmaceutical industry this year attended by more than 1,400 participants

UK invests in industrial biotechnologies, innovation and talents

Many initiatives are undergoing in UK in order to improve the global competitiveness of the country in the field of industrial biotechnologies, R&D activities for the manufacturing of small molecules, attraction of international talents and capital investments in innovation and research

Αccelerated assessment of PRIority Medicines (the PRIME programme)

Two years have gone since the launch of EMA’s PRIority Medicines scheme (PRIME). The Agency has published a report discussing its current state of implementation and suggesting opportunities to further improve the approval of innovative medicines for unmet medical needs

EU’s proposal of an SPC manufacturing waiver

The European Commission has formalised its proposal for an SPC manufacturing waiver. Debate is undergoing both at the European Parliament and associations representative of the different perspectives of originators' and generics' industries. Competitiveness, IP protection and research-based knowledge economy are at the center of comments issued by the interested parties

How artificial intelligence is changing the pharmaceutical industry

Artificial intelligence is deploying its full potential on the pharmaceutical industry, as machine learning and deep learning algorithms are opening new frontiers for drug discovery and diagnosis. Logistics and the provision of healthcare services shall also benefit from the new model, which is expected to impact also on the activities of pharmacies

EU: The European cooperation on Health Technology Assessment

The European Commission adopted the draft text of the new HTA regulation, which is expected to be examined and finally approved by the Parliament and Council of Europe by 2019. Committees of the European Parliament advanced their comments to the text, which aims to harmonise the current fragmented situation of HTA at the European level